Last reviewed · How we verify
[F-18]PBR06
F-18 PBR06 is a positron-emitting radiopharmaceutical used for imaging purposes.
F-18 PBR06 is a positron-emitting radiopharmaceutical used for imaging purposes. Used for Imaging of neuroinflammation.
At a glance
| Generic name | [F-18]PBR06 |
|---|---|
| Also known as | [18-F]PBR06, [F-18] PBR06, [18F]PBR06 |
| Sponsor | Brigham and Women's Hospital |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
F-18 PBR06 is a radiolabeled version of the compound PBR06, which is designed to bind to specific molecular targets. This allows for the visualization of these targets in the body using positron emission tomography (PET) imaging.
Approved indications
- Imaging of neuroinflammation
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- [F-18]PBR06 CI brief — competitive landscape report
- [F-18]PBR06 updates RSS · CI watch RSS
- Brigham and Women's Hospital portfolio CI